Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 15, 2025 • 1:00 PM ET

Date/Time Source News Release
06/12/2025 08:00 AM EDT GlobeNewswire Werewolf Therapeutics to Participate in the BIO International Convention
05/29/2025 08:00 AM EDT GlobeNewswire Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference
05/20/2025 04:01 PM EDT GlobeNewswire HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124
05/13/2025 08:00 AM EDT GlobeNewswire Werewolf Therapeutics to Participate in Hanson Wade's 6th Annual Cytokine-Based Drug Development Summit
05/08/2025 07:00 AM EDT GlobeNewswire Werewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
05/05/2025 08:05 AM EDT GlobeNewswire Werewolf Therapeutics Presents New Preclinical Data Further Characterizing its IL-10 INDUKINE Molecule, WTX-921, for the Treatment of Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
05/05/2025 08:00 AM EDT GlobeNewswire Werewolf Therapeutics to Participate in Upcoming Investor Conferences
04/17/2025 08:00 AM EDT GlobeNewswire Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer
03/31/2025 08:00 AM EDT GlobeNewswire Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
03/11/2025 07:00 AM EDT GlobeNewswire Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Page

Additional News

As of June 15, 2025 • 1:00 PM ET

Date/Time Source News Release
05/29/2025 12:00 PM EDT Zacks Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
05/08/2025 04:35 PM EDT SeekingAlpha Werewolf Therapeutics files $150M mixed securities shelf
05/08/2025 10:08 AM EDT SeekingAlpha Werewolf Therapeutics GAAP EPS of -$0.40 beats by $0.03
05/06/2025 05:10 PM EDT Zacks Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates
05/02/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Friday, May 2nd, 2025
05/02/2025 05:31 AM EDT US Earnings Reports Expected earnings - Werewolf Therapeutics Inc.
05/01/2025 06:48 PM EDT KlickAnalytics HOWL - Historical Price Movements Surrounding Earnings
05/01/2025 06:43 PM EDT KlickAnalytics HOWL - Historical Earnings Price Analysis
04/25/2025 10:00 AM EDT Zacks Earnings Preview: Werewolf Therapeutics, Inc. (HOWL) Q1 Earnings Expected to Decline
03/11/2025 09:33 AM EDT SeekingAlpha Werewolf Therapeutics GAAP EPS of -$0.46
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.